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Abstract
The main step in the assessment of
nanomaterial safety and suitability for
biomedical use is the location and the
dynamic tracking of nanoparticles (NPs)
inside cells or tissues. To precisely investi-
gate the uptake mechanisms and intracellu-
lar fate of NPs, transmission electron
microscopy is the technique of choice; how-
ever, the detection of NPs may sometimes
be problematic. In fact, while NPs contain-
ing strongly electron dense (e.g. metal)
components do not require specific detec-
tion methods at the ultrastructural level,
organic NPs are hardly detectable in the
intracellular environment due to their intrin-
sic moderate electron density. In this study,
the critical-electrolyte-concentration Alcian
Blue method set up by Schofield et al. in
1975 was applied to track hyaluronic-acid-
based NPs in muscle cells in vitro. This
long-established histochemical method
proved to be a powerful tool allowing to
identify not only whole NPs while entering
cells and moving into the cytoplasm, but
also their remnants following lysosomal
degradation and extrusion. 
Introduction
During the last two decades, a massive
number of nanoparticles (NPs) have been
developed with an increasing interest
towards biomedical applications.
Innovative nanoparticulate systems have
been investigated as e.g. drug carriers,
hyperthermia-inducing tools, contrast
agents, biosensors, sorting systems, scaffold
components.1-13 As an obvious conse-
quence, extensive in vitro and in vivo tests
have been applied to assess the suitability of
the nanosystems for their use in the biolog-
ical media and their functional efficacy. To
assess their toxicological profile, NPs are
commonly visualised and tracked inside
cells or tissues by conventional or confocal
fluorescence microscopy using fluorescent
markers.14 To precisely investigate the
uptake mechanisms and intracellular fate of
NPs, transmission electron microscopy
(TEM) is the technique of choice, although
the detection of NPs may sometimes be
problematic. NPs containing strongly elec-
tron dense components (e.g., iron, silver,
gold, silica) do not require specific detec-
tion methods,15-18 while fluorescently-
labelled nanoconstructs with intrinsic mod-
erate electron density (e.g., lipid- or poly-
mer-based NPs) can be made easily recog-
nizable by applying techniques of
diaminobenzidine (DAB) photo-
oxidation.19-20 However, this latter tech-
nique is not applicable to all fluorophores
since the success of the reaction depends on
the capability of the fluorescent agent to
generate reactive oxygen species in their
excited state; moreover, its application is
unfruitful in the presence of fluorescent
background or autofluorescent sample com-
ponents. 
Thanks to its high water-binding capac-
ity, biocompatibility and degradability, and
non-immunogenicity, hyaluronic acid (HA)
is of a great interest in the development of
nanoconstructs for a wide variety of
biomedical applications, from molecular
imaging to targeted drug delivery.21-23
In the frame of a study aimed at devel-
oping novel biocompatible HA-nanocarri-
ers,11 we observed that these HA-based NPs
exhibit a homogeneous and weak electron-
density that makes them hardly detectable
in the intracellular milieu; unfortunately, the
cell types used in our experiments (C2C12
immortalized murine muscle cells) showed
a strong intrinsic autofluorescence that pre-
vented to apply DAB photo-oxidation to
locate fluorescently-labelled HA-NPs at
TEM. We then decided to find an alternative
detection method to track the internalization
and intracellular traffic of these NPs at the
ultrastructural level. 
So far, the critical-electrolyte-concentra-
tion technique applied to the Alcian Blue
(AB) staining is a long-established histo-
chemical method to reveal glycosaminogly-
cans in tissue slices.24 In 1975, Schofield and
coll.25 used this histochemically specific
technique to localize and discriminate carti-
lage mucopolysaccharides at TEM; they also
improved the Scott and Dorling’s technique
demonstrating that the use of low concentra-
tions of AB after fixation resulted in a similar
staining pattern as after the original tech-
nique (that required the sample fixation and
staining be simultaneously performed). In
addition, this post-fixation procedure
enhanced dye staining by allowing its pene-
tration in the whole sample thickness, where-
as in the simultaneous fixation-staining
method the reaction was confined to the sam-
ple periphery. The staining consisted in elec-
tron dense fine granules that did not mask the
cellular structural components.
Based on the data present in the litera-
ture, we investigated an innovative applica-
tion of the AB method staining: we original-
ly applied the critical-electrolyte-concentra-
tion AB method set up by Schofield et al.25
to unequivocally detect HA-based NPs
administered to cultured cells   which has
been never tested before. 
Materials and Methods
HA-NPs were prepared by polyelec-
trolyte complexation, mixing HA (Lifecore
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Biomedical, Chaska, MN, USA) and poly-
arginine (PArg) (Polypeptide therapeutic
solutions, Valencia, Spain) with a molar
ratio HA/PArg of 5.77.11 To obtain fluores-
cent HA-NPs, 10% of the HA was conjugat-
ed with fluoresceinamine (Sigma-Aldrich,
Saint Louis, MA, USA) as previously
described.26 Dynamic light scattering was
used to characterized HA-NPs in terms of
hydrodynamic diameter, polydispersity
index (PDI) and Zeta potential (ζ), using
Zetasizer Nano ZS (Malvern Instruments
Limited, Malvern, UK). 
C2C12 myoblasts (an immortalized
murine cell line purchased from ATCC®
CRL-1772) were cultured in 75 cm² plastic
flasks using Dulbecco’s modified Eagle
medium, supplemented with 10% (v/v)
FBS, 1% (w/v) Glutamine, 0.5% (v/v)
Amphotericin B, 100 units/mL of Penicillin-
Streptomycin (Gibco, Waltham, MA, USA)
and incubated at 37°C with 5% CO2. Cells
were trypsinized in 0.05% EDTA in PBS
and seeded onto glass coverslips (12 mm in
diameter) in 24-multiwell (6x103 cells per
well). Twenty-four hours after seeding, the
cells were treated with 107 µg/mL of either
HA-NPs or fluorescent NPs for TEM and
bright field/fluorescence microscopy,
respectively. During the treatment the per-
centage of FBS was reduced to 5% (v/v) in
order to avoid NPs aggregation. Briefly,
cells were administered the HA-NPs for 2 h,
then the medium was removed and some
samples were immediately fixed (see
below) while others were given fresh medi-
um without NPs for further 22 h before
being fixed. These experimental conditions
were selected based on previous experi-
ments on cultured  muscle cells27, since by
this procedure the NPs that had not been
uptaken by cells were removed from the
medium, and it was possible to follow the
intracellular fate of the HA-NPs internalised
during the 2-h-incubation only. This avoids
possible cell overloading for long post-incu-
bation times, and limits the interference of a
medium possibly modified by the presence
of non-internalised NPs and/or the low FBS
concentration (it is worth recalling that
C2C12 myoblasts may differentiate into
myotubes when FBS concentration is main-
tained low for long times28). Untreated cell
samples were used as control. 
For bright field and fluorescence
microscopy, control cells and cells treated
with fluorescent HA-NPs were fixed with
4% (v/v) paraformaldehyde in PBS, pH 7.4
for 30 min at room temperature. Cells were
stained with 1% (w/v) Alcian blue  8GX
(Sigma, Saint Louis, MO, USA) in 3 %
(v/v) acetic acid for 2 h at room tempera-
ture, and differentiated in tap water;25 the
cells were counterstained with Nuclear fast
red (Bio-Optica, Milan, Italy) for 5 min at
room temperature, dehydrated through an
ascending series of ethanol, cleared in
xylene and finally mounted in Entellan
(Merck Millipore). The samples were
observed with an Olympus BX51 (Olympus
Italia Srl, Milan, Italy) microscope using a
60x objective either under bright field con-
ditions or in fluorescence (100 W mercury
lamp) using a 450-480 nm  exitation filter,
500 nm dichroic mirror, and 515 nm barrier
filter. Images were recorded with an
QICAM Fast 1394 digital camera
(QImaging, Surrey, BC, Canada) and pro-
cessed using Image-Pro Plus 7.0 software
(Media Cybernetics Inc., Rockville, MD,
USA).
Fluorescent HA-NPs were also stained
in suspension: briefly, 100 μL of AB  solu-
tion were mixed with an equal volume of
NPs solution for 2 h at room temperature. A
drop of suspension of these AB-stained HA-
NPs was placed onto a glass slide under a
coverslip, and  observed at the microscope,
under the same conditions as above. 
For TEM, control cells and cells treated
with HA-NPs were fixed with 3% (v/v) glu-
                             Technical Note
Figure 1. Fluoresceinamine-labelled HA-NPs in suspension as observed at conventional
fluorescence microscopy (a) and bright field microscopy after staining with AB (b). c,d)
A C2C12 myoblast after 24 h incubation with fluoresceinamine-labelled HA-NPs: the
fluorescent signal of NPs (c) mostly overlaps AB staining (d) (encircled areas). Note the
high intracellular fluorescence background in (c). Scale bars: 10 µm.
Figure 2. Transmission electron micrographs of C2C12 myoblasts, conventional ultra-
structural morphology: a HA-NP (arrow) adheres to the cell surface (a) and residual bod-
ies (asterisks) accumulate in the cytoplasm and sometimes bud from the cell surface
(arrowhead) (b). Scale bars:  200 nm.
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taraldehyde in PBS pH 7 for 30 min at room
temperature, treated with AB as for light
microscopy,25 post-fixed with 1% OsO4 for
1 h at room temperature, dehydrated with
acetone and embedded in Epon resin as pre-
viously described.29 As a control of staining
specificity, some samples were processed as
above described but, before AB treatment,
the cells were incubated with 1 mg/ml of
hyaluronidase (Sigma H3506) in normal
saline for 1 h at room temperature. Ultrathin
sections were observed without lead stain-
ing in a Philips Morgagni transmission elec-
tron microscope (FEI Company Italia Srl,
Milan, Italy) operating at 80 kV and
equipped with a Megaview II camera  for
digital image acquisition. The images were
processed using Image-Pro Plus 7.0 soft-
ware (Media Cybernetics Inc., Silver
Spring, MD, USA).
Results and Discussion
HA-NPs showed a hydrodynamic size
of 200 nm, a low PDI <0.1, and negative ζ
potential ranging from -24 to -18 mV.
After AB staining in suspension, fluo-
rescent HA-NPs (Figure 1a) appeared as
blue dots at bright field microscopy (Figure
1b). Similarly, after NPs internalization in
cultured cells, fluorescent HA-NPs
appeared as bright green areas or spots
(Figure 1c), while they appeared as blue
clusters at bright field microscopy (Figure
1d). The overlapping of the blue staining
with the green fluorescence signal demon-
strated the specificity of the AB reaction for
HA-NPs (Figure 1c,d). However, some AB-
stained NPs did not match fluorescent NPs:
this could be due to combined effect of the
cell auto-fluorescence and the release of
fluoresceinamine from NPs undergoing
enzymatic degradation, which lowers NPs
brightness, and the fluorescent signal occur-
ring in the intracellular milieu, which masks
NPs fluorescence. As for cell fluorescence,
it should be underlined that C2C12
myoblasts show an intrinsic green auto-flu-
orescence that appeared to be increased
after incubation with fluoresceinamine-
labelled HA-NPs (not shown), thus support-
ing the hypothesis of the fluoresceinamine
spreading following NPs degradation.
At TEM, the AB staining appeared as an
irregular granular electron dense product, as
Schofield et al. observed in cartilage sam-
ples.25 In cells treated with HA-NPs, the AB
staining was found on roundish structures
with a moderate electron density corre-
sponding to the NPs observed in unstained
samples (Figure 2a) and to the size evaluat-
ed by dynamic light scattering. Stained NPs
were observed adhering to the cell surface
and inside invaginations of the plasma
membrane (Figure 3 a,b). This evidence of
the very early events in the NP uptake pro-
cess was obtained thanks to the procedure
of embedding cells as monolayers29, which
allows an optimal preservation of the spatial
relationships between NPs and the plasma
membrane. The AB staining was observed
on intracellular NPs occurring either inside
endosomes (Figure 3c) or free in the cytosol
(Figure 3d). The occurrence of NPs free in
the cytosol likely facilitates the release of
fluorescent molecules, thus increasing the
intracellular background visible at fluores-
cence microscopy.
The high concentration of HA in our
NPs certainly promoted their intense AB-
positivity at TEM. However, some AB
staining was also clearly visible in large
roundish structures (300 to 600 nm in diam-
eter) occurring as clusters in the cytoplasm
(Figure 3e), according to what observed in
unstained samples (Figure 2b). We hypothesize
that they represent NP residual bodies. In
these residual bodies AB staining was pref-
erentially located at the periphery, suggest-
ing a compartmentalization of HA. To con-
firm the high sensitivity of AB staining at
the ultrastructural level, the presence of HA
was still recognizable as AB-positivity even
when the residual bodies were found to be
extruded from the cell (Figure 3f), probably
due to NPs overloading.
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Figure 3. Transmission electron micrographs of C2C12 myoblasts after AB staining. a,b)
The electron dense, granular reaction product occurs in HA-NPs (arrows) adhering to the
cell surface. c) Three AB-stained HA-NPs are enclosed inside endosomes (arrowheads),
just beneath the cell surface. d) A HA-NP free in the cytosol (open arrow) is clearly rec-
ognizable in the intracellular milieu. e) Residual bodies containing HA (asterisks) accu-
mulate in the cytoplasm (e) and are extruded from the cell (f ). Scale bars: 200 nm.
Figure 4. Sample treated with hyaluronidase as AB staining control: note the absence of
any specific staining, especially in the residual bodies (asterisks). Scale bar: 200 nm.
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No granular electron dense product was
ever found in cells incubated with
hyaluronidase before AB treatment, thus
demonstrating the specificity of the staining
procedure for HA at TEM (Figure 4). In
addition, no granular reaction was observed
in cell organelles of any cell samples or in
control cells (not exposed to NPs), consis-
tently with the evidence that intracellular
HA is expressed only under particular con-
dition such as inflammation.30
The overall appearance of AB-stained
cells was similar as in samples routinely-
processed for conventional ultrastructural
morphology (Figure 2), although the intrin-
sic contrast was lower likely due to protein
extraction during the staining at acid pH.
Nevertheless, it is preferable to avoid the
contrast-enhancing staining with lead cit-
rate or uranyl acetate in samples treated
with AB because both reagents produce a
noisy fine pepper-like precipitate.
In addition to AB staining, other tech-
niques have been developed for HA detec-
tion at the ultrastructural level, among
which the periodic acid-Schiff method,31-33
ruthenium red staining,34 cationized ferritin
binding,35,36 high iron diamine method,37
gold-conjugated hyaluronidase diges-
tion,38,39 labelled HA-binding probes.40,41
These techniques often require special fixa-
tion procedures, whereas the AB staining is
a simple and reliable method for the specif-
ic detection of HA in subcellular domains,
which may be suitable for both light and
electron microscopy under the usual fixa-
tion conditions for conventional ultrastruc-
tural morphology. 
Our results demonstrated that the criti-
cal-electrolyte-concentration AB-staining is
a powerful tool to thoroughly describe how
HA-based NPs do interact with cells in cul-
ture, allowing to identify not only whole
NPs while entering cells and moving into
the cytoplasm, but also their remnants fol-
lowing lysosomal degradation and extru-
sion. This proves that this long-established
staining method may successfully find
application in a frontline research domain
such as nanotechnology, namely for the
ultrastructural study of scarcely electron-
dense nanoconstructs that are especially
promising drug carriers.
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